Skip to main content
OpenTrials
Completed

NCT Number: NCT04991558

Feasibility and Effectiveness of a Coordinated Healthcare Circuit Dedicated to Patients With Handicap

France currently has more than 10 million disabled people, including 3 millions who could be better treated. In fact, people with disabilities face many obstacles in accessing care and receiving appropriate support (physical access to certain locations, communication...). Difficulties are also encountered by the healthcare staff, leading to often heterogeneous practices in health establishments.

The INFRA health circuit has been set up at the "Groupe Hospitalier Mutualiste de Grenoble" since June 2018 according to the guidelines published by the French High Authority for Health (HAS) on improving professional practices "Reception, support and organization of care in health establishments for people in situation of handicap "of July 2017. The INFRA nurse collects and anticipates the necessary adaptations for the patient's stay, in conjunction with their caregivers (whether family or institutional). They are an interface with other healthcare professionals to adapt care procedures and protocols (body care, feeding methods, pain management, drug management) to the patient's disability. Before hospitalization and until the patient is discharged, the INFRA nurse transmits to the personnel involved all the information necessary for the proper continuation of care. In addition to legal and regulatory obligations, the INFRA nurse ensures the effective accessibility of the establishment's facilities and premises, and helps maintaining patient autonomy.

The INFRA study is an observational study aimed at assessing the feasibility of the INFRA health circuit and evaluating the benefit for the patients and the healthcare staff.

Completed

Looking for future studies?

Notify Me

Key information

Age range

13 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Groupe Hospitalier Mutualiste de Grenoble

Grenoble, 38028, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 13 years old or more
  • Physical or mental disability, according to french law n°2005-102 of February 11th, 2005
  • Requiring an adaptation of the healthcare circuit
  • Indication of a planned surgical procedure

Exclusion criteria

  • Outpatient
  • Emergency surgery

Treatment and study plan

Primary outcomes

  1. Number of patients who followed the entirety of INFRA circuit

    Time frame: At discharge, assessed up to 4 weeks

Secondary outcomes

  1. Type of pain evaluation scale selected by the INFRA nurse

    Time frame: enrollment

  2. Number of healthcare adaptations implemented during hospitalization

    Time frame: At discharge, assessed up to 4 weeks

  3. Satisfaction of patients and caregivers

    Time frame: At discharge, assessed up to 4 weeks

    Satisfaction survey answered by patients and caregivers

  4. Satisfaction of healthcare staff

    Time frame: At discharge, assessed up to 4 weeks

    Satisfaction survey answered by healthcare staff

Sponsors and collaborators

Lead sponsor

Groupe Hospitalier Mutualiste de Grenoble

Other

Registry information

Official study title

Prospective, Single-center Observational Study to Assess the Feasibility and Evaluate the Effectiveness of a Coordinated Healthcare Circuit Dedicated to Patients With Mental and Physical Disabilities Undergoing Planned Surgery

Acronym: INFRA

Important dates

Study start
2020
Primary completion
2022
Study completion
2022
First posted
Aug 5, 2021
Registry last updated
Mar 7, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.